Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Closes $370M Acquisition of JRH Biosciences

NEW YORK, March 1 (GenomeWeb News) - Sigma-Aldrich today announced the completion of its previously announced acquisition of JRH Biosciences.


The acquisition, which was originally announced on Jan. 18, is worth $370 million.


JRH, headquartered in Lenexa, Kan., supplies cell culture and sera products to the biopharmaceutical industry. It had approximately $150 million in sales in 2004, and was expecting 10-percent growth in sales in 2005, Sigma said.


Ten months of JRH's operating results will be added to Sigma-Aldrich's 2005 performance, Sigma said.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.